Behavioural, Neurochemical, and Brain Histomorphological Effects of Repeated Propofol Administration in Wistar Rats
Abstract
Propofol is a widely used intravenous anaesthetic whose principal central nervous system action involves potentiation of γ-aminobutyric acid type A (GABA_A) receptor-mediated inhibitory neurotransmission. Although propofol has recognised neuroprotective, antioxidant, and anti-inflammatory properties, repeated or prolonged exposure may produce dose- and context-dependent neural alterations. This study investigated the behavioural, circulating neurochemical, biochemical, and brain histomorphological effects of repeated propofol administration in Wistar rats. Forty Wistar rats, comprising 20 males and 20 females, were allocated to four groups (n = 10; 5 males and 5 females per group): control, 0.5, 1.0, and 1.5 mg/kg propofol groups. Behavioural assessments included the open-field test, elevated plus maze, and Y-maze, while body weight and feed intake were monitored. Serum dopamine, acetylcholine, serotonin, malondialdehyde (MDA), total antioxidant capacity (TAC), tumour necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-10 (IL-10) were determined. The dentate gyrus and prefrontal cortex were examined histologically. Data were analysed using one-way analysis of variance followed by Tukey’s multiple-comparison test. Repeated propofol exposure significantly altered feed intake, line crossing, rearing, elevated-plus-maze behaviour, and Y-maze performance, whereas body weight and self-grooming were not significantly altered. Serum dopamine decreased progressively, whereas acetylcholine increased at the medium and high doses. MDA increased significantly, accompanied by increased TAC at the highest dose. TNF-α and IL-10 were significantly reduced, whereas IL-1β was unchanged. Histological examination demonstrated dose-related neuronal distortion and degenerative changes in the dentate gyrus and prefrontal cortex. Repeated propofol administration was associated with behavioural, circulating neurochemical, biochemical, and brain histomorphological alterations following repeated propofol exposure.